2009: Assessing benefit without considering harm?
In addition to assessing desirable effects and (additional) benefit, IQWiG is also required by law to assess the possible harm of medical interventions. However, assessing the harm of therapies is not as well defined in systematic reviews and HTA reports as assessing the benefit. Consequently in 2009 "IQWiG in dialogue" addressed various aspects concerned with assessing harmful effects.